We are using cookies in order to offer you the most relevant information. We have published
new Cookie Policy which you should read to find out more. more
Please accept cookies for optimal performance.

Press Release

Cardio-HART™ - a Breakthrough Cardiac-Telemedicine™ device, now CE-Marked

Cardio-HART™ - a Breakthrough Cardiac-Telemedicine™ device, now CE-Marked

Cardio-HART™, a Breakthrough Heart Diagnostic device is CE Marked, just in time to address Europe’s Pandemic consequences of COVID-19. Just in time to meet the consequences of COVID-19 caused heart disease, CHART has obtained CE Mark certification for use in the EU.  With Europe’s vaunted medical systems strained to a breakpoint as a result of COVID-19, they...
Read more

AI innovations in primary care

AI innovations in primary care

for immediate release Toronto, Canada. On December 14th, Cardio-Phoenix Inc. received a 510 (k) clearance for its Cardio-TriTest™ v6.5 medical device from the U.S Food and Drug Administration (FDA). This is the second 510k the company has received, the first being issued June 3rd, 2015. The Cardio-TriTest™ (CTT) device is a non-invasive medical device that collects 3...
Read more

Cardio Phoenix is now ISO13485:2016 certified

Cardio Phoenix is now ISO13485:2016 certified

Cardio-Phoenix Inc. -  Now ISO 13485:2016 Certified Cardio–Phoenix Inc. is proud to announce that it has received the coveted ISO 13845:2016 certification for the Design and Development of non-invasive diagnostic medical devices. ISO certification of Cardio-Phoenix demonstrates the company’s quality commitment to developing advanced products and novel technology for the early detection of a broad range of...
Read more